Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-10-31T23:05:33.231Z Has data issue: false hasContentIssue false
  • English
  • Français

Impact of pain and remission in the functioning of patients with depression in China

Published online by Cambridge University Press:  23 March 2020

D. Novick ,
Q. Shi ,
L. Yue ,
W. Montgomery ,
M.V. Moneta ,
S. Siddi  and
J.M. Haro
D. Novick*
Affiliation:
Eli Lilly and Company, Windlesham, Surrey, UK
Q. Shi
Affiliation:
Lilly Suzhou Pharmaceutica Company, Ltd., Shanghai, China
L. Yue
Affiliation:
Lilly Suzhou Pharmaceutica Company, Ltd., Shanghai, China
W. Montgomery
Affiliation:
Eli Lilly Australia Pty Ltd, West Ryde, Australia
M.V. Moneta
Affiliation:
Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain
S. Siddi
Affiliation:
Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain Section of Clinical Psychology, Department of Education, Psychology, Philosophy, University of Cagliari, Italy
J.M. Haro
Affiliation:
Parc Sanitari Sant Joan de Déu, Fundació Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Barcelona, Spain
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Major depressive disorder (MDD) is the second leading cause of disability in China.

Objective

To analyze functioning during the course of treating MDD in China, Taiwan and Hong Kong.

Aims

To study the influence of pain and clinical remission on functioning.

Methods

This was a post-hoc analysis of a 6-month, prospective, observational study (n = 909) with 422 patients enrolled from China (n = 205; 48.6%), Taiwan (n = 199; 47.2%) and Hong Kong (n = 18; 4.2%). Functioning was measured with the Sheehan Disability Scale (SDS), pain with the Somatic Symptom Inventory, and severity of depression with the Quick Inventory of Depressive Symptomatology-Self Report 16 (QIDS). Patients were classified as having no pain, persistent pain (pain at any visit) or remitted pain (pain only at baseline). A mixed model with repeated measures was fitted to analyze the relationship between pain and functioning.

Results

At baseline, 40% of the patients had painful physical symptoms. Patients with pain had a higher QIDS and lower SDS (P < 0.05) at baseline. At 6 months, patients with persistent pain had lower functioning (P < 0.05). The regression model confirmed that clinical remission was associated with higher functioning at endpoint and that patients with persistent pain had lower functioning at endpoint when compared with the no pain group.

Conclusions

Patients presenting with pain symptoms had lower functioning at baseline. At 6 months, pain persistence was associated with significantly lower functioning as measured by the SDS. Clinical remission was associated with better functional outcomes. The course of pain was related to the likelihood of achieving remission.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV528
Information
European Psychiatry , Volume 33 , Issue S1: Abstracts of the 24th European Congress of Psychiatry , March 2016 , pp. S419
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.